Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

Open Access Editorial

Biotechnology entrepreneurship - where no research has gone before

Michael L Salgaller1* and Francesco M Marincola2

Author Affiliations

1 thinkBiotech, LLC, Washington, DC 20009, USA

2 Infectious Disease and Immunogenetics Section (IDIS) - Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892. USA

For all author emails, please log on.

Journal of Translational Medicine 2010, 8:102  doi:10.1186/1479-5876-8-102

Published: 15 October 2010

First paragraph (this article has no abstract)

Many researchers have a scientific interest in taking their translational studies from bench to bedside. They want to take their ideas and see how far they can go towards bringing medical solutions to as many patients as possible. However, it can be frustrating when the clinical development of their work is beyond the scope and capabilities of their university or hospital. Even for those institutions with research beds, studies are usually limited to small, pilot studies. Even for those institutions with the necessary financial support, the manufacturing, regulatory, and legal essentials are not in place to evolve such studies to larger, later-stage human trials. This is nothing new. What is new is the rising tide of researchers turning to the for-profit world. Either directly - by starting their own companies, or indirectly - by working with existing pharmaceutical and biotechnology companies, researchers are moving more and more technologies towards the marketplace. Biotechnology Entrepreneurship: From Science to Solutions provides a real-world introduction to starting and growing life science companies, as well as useful material for medical researchers interested in getting their technologies to as many patients as possible.